226 related articles for article (PubMed ID: 20371357)
1. A real-time fluorescent assay of the purified nitric oxide receptor, guanylyl cyclase.
Newton M; Niewczas I; Clark J; Bellamy TC
Anal Biochem; 2010 Jul; 402(2):129-36. PubMed ID: 20371357
[TBL] [Abstract][Full Text] [Related]
2. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
[TBL] [Abstract][Full Text] [Related]
4. Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra.
Toque HA; Antunes E; Teixeira CE; De Nucci G
Urology; 2008 Sep; 72(3):711-5. PubMed ID: 18359064
[TBL] [Abstract][Full Text] [Related]
5. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
[TBL] [Abstract][Full Text] [Related]
6. Structure/activity relationships of (M)ANT- and TNP-nucleotides for inhibition of rat soluble guanylyl cyclase α1β1.
Dove S; Danker KY; Stasch JP; Kaever V; Seifert R
Mol Pharmacol; 2014 Apr; 85(4):598-607. PubMed ID: 24470063
[TBL] [Abstract][Full Text] [Related]
7. Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator.
Nakane M; Kolasa T; Chang R; Miller LN; Moreland RB; Brioni JD
J Pharmacol Sci; 2006 Oct; 102(2):231-8. PubMed ID: 17050951
[TBL] [Abstract][Full Text] [Related]
8. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells.
Borges de Oliveira-Junior E; Thomazzi SM; Rehder J; Antunes E; Condino-Neto A
Eur J Pharmacol; 2007 Jul; 567(1-2):43-9. PubMed ID: 17499238
[TBL] [Abstract][Full Text] [Related]
9. Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells.
Bähre H; Danker KY; Stasch JP; Kaever V; Seifert R
Biochem Biophys Res Commun; 2014 Jan; 443(4):1195-9. PubMed ID: 24380860
[TBL] [Abstract][Full Text] [Related]
10. Efficient expression of human soluble guanylate cyclase in Escherichia coli and its signaling-related interaction with nitric oxide.
Zhong F; Wang H; Ying T; Huang ZX; Tan X
Amino Acids; 2010 Jul; 39(2):399-408. PubMed ID: 20063108
[TBL] [Abstract][Full Text] [Related]
11. Structure and regulation of soluble guanylate cyclase.
Derbyshire ER; Marletta MA
Annu Rev Biochem; 2012; 81():533-59. PubMed ID: 22404633
[TBL] [Abstract][Full Text] [Related]
12. The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.
Bellamy TC; Garthwaite J
Mol Cell Biochem; 2002 Jan; 230(1-2):165-76. PubMed ID: 11952092
[TBL] [Abstract][Full Text] [Related]
13. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
Kostic TS; Andric SA; Stojilkovic SS
Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
[TBL] [Abstract][Full Text] [Related]
14. Measurement of cGMP and soluble guanylyl cyclase activity.
Southam E
Curr Protoc Toxicol; 2001 May; Chapter 10():Unit 10.5. PubMed ID: 23045027
[TBL] [Abstract][Full Text] [Related]
15. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 receptors via Gbetagamma-dependent activation of c-Src kinase.
Murthy KS
J Pharmacol Exp Ther; 2008 Apr; 325(1):183-9. PubMed ID: 18180373
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
Knorr A; Hirth-Dietrich C; Alonso-Alija C; Härter M; Hahn M; Keim Y; Wunder F; Stasch JP
Arzneimittelforschung; 2008; 58(2):71-80. PubMed ID: 18412020
[TBL] [Abstract][Full Text] [Related]
18. Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.
Vanneste G; Dhaese I; Sips P; Buys E; Brouckaert P; Lefebvre RA
J Physiol; 2007 Nov; 584(Pt 3):907-20. PubMed ID: 17717014
[TBL] [Abstract][Full Text] [Related]
19. Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1.
Beste KY; Burhenne H; Kaever V; Stasch JP; Seifert R
Biochemistry; 2012 Jan; 51(1):194-204. PubMed ID: 22122229
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries.
Pearce WJ; Williams JM; White CR; Lincoln TM
J Appl Physiol (1985); 2009 Jul; 107(1):192-9. PubMed ID: 19407253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
